|
Overcoming a newly recognized form of resistance to modern prostate cancer drugs
|
8
|
Zenith Epigenetics
|
Jun 20, 2021 09:39AM
|
|
OncLive article mentioning ZEN-3694
|
5
|
Zenith Epigenetics
|
Jun 15, 2018 07:02PM
|
|
NYAS Symposium on Apr 28
|
6
|
Resverlogix Corp.
|
Apr 18, 2016 08:19PM
|
|
Novartis' canakinumab (Ilaris)
|
4
|
Resverlogix Corp.
|
Mar 13, 2018 01:32PM
|
|
Nice background article on mCRPC
|
5
|
Zenith Epigenetics
|
Oct 02, 2016 08:29PM
|
|
New shares issued?
|
5
|
Zenith Epigenetics
|
Aug 07, 2018 08:36AM
|
|
New Interim Financials and MD&A docs on SEDAR
|
4
|
Zenith Epigenetics
|
Mar 30, 2016 03:35PM
|
|
New Interim Financials and MD&A docs on SEDAR
|
5
|
Resverlogix Corp.
|
Dec 16, 2015 10:45AM
|
|
New docs on SEDAR
|
6
|
Zenith Epigenetics
|
Jan 01, 2016 10:27AM
|
|
New compound - ApaBearDownAzone
|
9
|
Resverlogix Corp.
|
Jun 01, 2017 03:10PM
|
|
It seems ...
|
6
|
Resverlogix Corp.
|
Nov 09, 2015 12:43PM
|
|
Israel Patent Application
|
5
|
Resverlogix Corp.
|
Jan 10, 2018 08:49AM
|
|
Is CellCentric a competitor?
|
2
|
Zenith Epigenetics
|
May 15, 2018 06:27PM
|
|
Inventory and Revenue calcs
|
9
|
Resverlogix Corp.
|
May 13, 2021 11:01AM
|
|
Institutional Investors
|
1
|
Resverlogix Corp.
|
Dec 11, 2020 07:02PM
|
|
Hepalink Anniversary - Apr 27
|
9
|
Resverlogix Corp.
|
Apr 25, 2016 06:21PM
|
|
Gap up this morning
|
4
|
Resverlogix Corp.
|
Nov 09, 2015 09:41AM
|
|
Forced buy ins
|
3
|
Resverlogix Corp.
|
Jun 13, 2018 03:19PM
|
|
FDA halts use of antibody drugs that don't work vs. omicron
|
6
|
Resverlogix Corp.
|
Jan 24, 2022 06:41PM
|
|
Even DM must take PCR tests (at least up to Feb 28)
|
9
|
Resverlogix Corp.
|
Mar 02, 2022 05:25PM
|
